Increased concentration of plasma TNFR1 and TNFR2 in paediatric lupus nephritis

Lupus

Volumn 25, Issue 9, 2016, Pages 1040-1044

  Patel, M ^a   Oni, L ^a,b   Midgley, A ^a   Smith, E ^a,b   Tullus, K ^c   Marks, S D ^c   Jones, C A ^c   Pilkington, C ^c   Beresford, M W ^a,b  

^a UNIVERSITY OF LIVERPOOL   (United Kingdom)

^b ALDER HEY CHILDREN'S NHS FOUNDATION TRUST   (United Kingdom)

^c GREAT ORMOND STREET HOSPITAL   (United Kingdom)

Author keywords

Nephritis; renal lupus; systemic lupus erythematosus

Indexed keywords

CREATININE; DOUBLE STRANDED DNA ANTIBODY; TUMOR NECROSIS FACTOR RECEPTOR 1; TUMOR NECROSIS FACTOR RECEPTOR 2; SERUM ALBUMIN; TNFRSF1A PROTEIN, HUMAN; TNFRSF1B PROTEIN, HUMAN;

ADOLESCENT; ANALYTICAL PARAMETERS; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; HUMAN; JUVENILE ONSET SYSTEMIC LUPUS ERYTHEMATOUS; LUPUS ERYTHEMATOSUS NEPHRITIS; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SYSTEMIC LUPUS ERYTHEMATOSUS; URINARY ALBUMIN CREATININE RATIO; BLOOD; METABOLISM; ONSET AGE; UPREGULATION; URINE;

ADOLESCENT; AGE OF ONSET; CHILD; CREATININE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LUPUS NEPHRITIS; MALE; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE I; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II; SERUM ALBUMIN; UP-REGULATION;

EID: 84978252400     PISSN: 09612033     EISSN: 14770962     Source Type: Journal    
DOI: 10.1177/0961203316631634     Document Type: Article

References (16)

1. Marks SD, Williams SJ, Tullus K, Sebire NJ,. Glomerular expression of monocyte chemoattractant protein-1 is predictive of poor renal prognosis in pediatric lupus nephritis. Nephrol Dial Transplant 2008; 23: 3521-3526.
2. Al-Lamki RS, Wang J, Skepper JN, Thiru S, Pober JS, Bradley JR,. Expression of tumor necrosis factor receptors in normal kidney and rejecting renal transplants. Lab Invest 2001; 81: 1503-1515.
3. Horiuchi T, Mitoma H, Harashima S, Tsukamoto H, Shimoda T,. Transmembrane TNF-alpha: Structure, function and interaction with anti-TNF agents. Rheumatology 2010; 49: 1215-1228.
4. Idasiak-Piechocka I, Oko A, Pawliczak E, Kaczmarek E, Czekalski S,. Urinary excretion of soluble tumour necrosis factor receptor 1 as a marker of increased risk of progressive kidney function deterioration in patients with primary chronic glomerulonephritis. Nephrol Dial Transplant 2010; 25: 3948-3956.
5. Neale TJ, Rüger BM, Macaulay H, et al. Tumor necrosis factor-alpha is expressed by glomerular visceral epithelial cells in human membranous nephropathy. Am J Pathol 1995; 146: 1444-1454.
6. Matsumura R, Umemiya K, Sugiyama T, et al. Anti-tumor necrosis factor therapy in patients with difficult-to-treat lupus nephritis: A prospective series of nine patients. Clin Exp Rheumatol 2009; 27: 416-421.
7. Marks SD, Pilkington C, Woo P, Dillon MJ,. The use of the British Isles Lupus Assessment Group (BILAG) index as a valid tool in assessing disease activity in childhood-onset systemic lupus erythematosus. Rheumatology 2004; 43: 1186-1189.
8. Munroe ME, Vista ES, Guthridge JM, Thompson LF, Merrill JT, James JA,. Proinflammatory adaptive cytokine and shed tumor necrosis factor receptor levels are elevated preceding systemic lupus erythematosus disease flare. Arthritis Rheumatol 2014; 66: 1888-1899.
9. Gabay C, Cakir N, Moral F, et al. Circulating levels of tumor necrosis factor soluble receptors in systemic lupus erythematosus are significantly higher than in other rheumatic diseases and correlate with disease activity. J Rheumatol 1997; 24: 303-308.
10. Davas EM, Tsirogianni A, Kappou I, Karamitsos D, Economidou I, Dantis PC,. Serum IL-6, TNFalpha, p55 srTNFalpha, p75srTNFalpha, srIL-2alpha levels and disease activity in systemic lupus erythematosus. Clin Rheumatol 1999; 18: 17-22.
11. Aderka D, Sorkine P, Abu-Abid S, et al. Shedding kinetics of soluble tumor necrosis factor (TNF) receptors after systemic TNF leaking during isolated limb perfusion. Relevance to the pathophysiology of septic shock. J Clin Invest 1998; 101: 650-659.
12. Mahmoud RA, El-Gendi HI, Ahmed HH,. Serum neopterin, tumor necrosis factor-alpha and soluble tumor necrosis factor receptor II (p75) levels and disease activity in Egyptian female patients with systemic lupus erythematosus. Clin Biochem 2005; 38: 134-141.
13. Studnicka-Benke A, Steiner G, Petera P, Smolen JS,. Tumour necrosis factor alpha and its soluble receptors parallel clinical disease and autoimmune activity in systemic lupus erythematosus. Br J Rheumatol 1996; 35: 1067-1074.
14. Vielhauer V, Stavrakis G, Mayadas TN,. Renal cell-expressed TNF receptor 2, not receptor 1, is essential for the development of glomerulonephritis. J Clin Invest 2005; 115: 1199-1209.
15. Berger SP, Roos A, Daha MR,. Complement and the kidney: What the nephrologist needs to know in 2006? Nephrol Dial Transplant 2005; 20: 2613-2619.
16. Chung CH, Fan J, Lee EY, et al. Effects of tumor necrosis factor-alpha on podocyte expression of monocyte chemoattractant protein-1 and in diabetic nephropathy. Nephron Extra 2015; 5: 1-18.